Department of Dermatology, Chaim Sheba Medical Center, Tel Hashomer, Israel; The Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Br J Dermatol. 2014 Nov;171(5):1078-83. doi: 10.1111/bjd.13005. Epub 2014 Oct 28.
Onchocerciasis is an infectious disease caused by the filaria Onchocerca volvulus. Very little is known regarding onchocerciasis imported from endemic to nonendemic areas.
To evaluate pruritic dermatitis simulating atopic dermatitis in Ethiopian immigrants in Israel.
A retrospective study of 27 Ethiopian immigrants to Israel was conducted. Demographics and clinical and laboratory data were collected.
Of the group of 27 patients, 10 (37%) were men and 17 (63%) were women. The average age at referral was 29 years. All of the patients emigrated from Kuwara, Ethiopia. Diagnosis was done by either positive skin snip test or immunoglobulin (Ig) G4 serology of onchocerciasis in 14 patients. The most common presentation was a combination of lichenified onchodermatitis with atrophy and depigmentation (36%). Eosinophilia and elevated IgE levels were common. Seventeen patients were treated with a single administration of oral ivermectin 200 μg mg(-1). Thirteen patients responded to the treatment.
Immigrants from endemic regions to developed countries presenting with pruritic diseases, especially those with a clinical picture suggestive of atopic dermatitis, should be evaluated for possible onchocerciasis infection. Ivermectin, a relatively safe and low-cost treatment, should be considered even in the absence of a proven disease. Physicians should have a high index of suspicion in patients with the corresponding residential history.
盘尾丝虫病是一种由盘尾丝虫引起的传染病。关于从流行地区输入到非流行地区的盘尾丝虫病,人们知之甚少。
评估以色列埃塞俄比亚移民中类似特应性皮炎的瘙痒性皮肤病。
对 27 名移民到以色列的埃塞俄比亚人进行了回顾性研究。收集了人口统计学、临床和实验室数据。
在这 27 名患者中,10 名(37%)为男性,17 名(63%)为女性。转诊时的平均年龄为 29 岁。所有患者均来自埃塞俄比亚的库瓦拉。14 例患者通过皮肤划痕试验或盘尾丝虫病 IgG4 血清学检查确诊。最常见的表现是苔藓样变伴萎缩和色素减退的硬结性虫斑性皮炎(36%)。嗜酸性粒细胞增多和 IgE 水平升高很常见。17 名患者单次口服伊维菌素 200μg·mg(-1)进行治疗。13 名患者对治疗有反应。
来自流行地区的移民到发达国家后出现瘙痒性疾病,特别是那些临床表现提示特应性皮炎的患者,应评估其是否感染盘尾丝虫病。即使没有明确的疾病,伊维菌素作为一种相对安全且低成本的治疗方法,也应考虑使用。对于有相应居住史的患者,医生应保持高度警惕。